Home / Conditions / Obesity (page 5)

Obesity

Obesity and Diabetes: Diabetes patients are considered obese when they have a Body Mass Index over 30. Such patients are at greater risk for a host of other problems cardiovascular disease, cancer, sleep apnea, and poor quality of life. Tremendous research is being done to control, manage, and reverse obesity in diabetics and the educated healthcare professional can help.

GLP‑1s in Type 1 Diabetes With Obesity: When Do the 2026 Rules Say “Yes”?

A woman with type 1 diabetes and obesity consults with her doctor about GLP‑1 therapy, with insulin and diabetes tools visible.

Imagine managing type 1 diabetes and still gaining weight despite careful insulin use, exercise, and carb counting. That’s the frustrating reality for many people living with T1D and obesity. While insulin is life-saving, it can also promote weight gain, making the balance between glucose control and healthy weight even harder. …

Read More »

GLP‑1s in Menopause: Using Incretins to Protect Cardiometabolic Health in Midlife

Middle-aged woman smiling in a medical office, holding a medication bottle to represent GLP‑1 therapy during menopause.

Menopause marks a major transition in a woman’s life, defined not only by the end of menstrual cycles but also by profound hormonal and metabolic changes. One often under‑recognized shift is the acceleration of cardiometabolic risk. Women in midlife frequently experience increased central adiposity, changes in glucose regulation, rising blood …

Read More »

GLP‑1s and Liver Disease: Rethinking MASLD Care Beyond Obesity and A1C

3D liver with fatty deposits, GLP-1 injection pen, stethoscope, molecular structures, and test results for liver enzymes

Nonalcoholic steatohepatitis (NASH) and metabolic dysfunction–associated steatotic liver disease (MASLD) are rapidly becoming leading causes of chronic liver disease worldwide. Traditionally, clinicians have associated MASLD with obesity, insulin resistance, and type 2 diabetes, often using body mass index (BMI) and A1C as screening triggers. However, an important shift is occurring …

Read More »

Prescribing GLP‑1s for Obesity Without Diabetes: How to Treat “Normoglycemic” Risk

A doctor holding a GLP‑1 injection pen while consulting with a woman about obesity treatment, surrounded by medical tools and healthy food.

In recent years, GLP‑1-based treatments for obesity have evolved from being primarily a diabetes-focused strategy to becoming a powerful tool for managing weight and reducing cardiometabolic risk—especially in individuals without type 2 diabetes. This growing trend is shifting how clinicians identify and manage obesity, moving beyond A1C levels to a …

Read More »

GLP‑1s for PCOS: From Insulin Resistance to Cycle Control

Woman using GLP‑1 injection with PCOS medical tools in clinical setting

Could a diabetes medication help women with PCOS regain control of their cycles and metabolism? GLP‑1 receptor agonists, best known for treating type 2 diabetes and obesity, are showing promise for women with polycystic ovary syndrome (PCOS). These medications may support weight loss, improve insulin resistance, and even lead to …

Read More »

Can GLP‑1s Help Curb Alcohol Use? What Diabetes Clinicians Should Know

GLP-1 injection pen beside glasses of alcohol on a doctor's desk, representing potential alcohol use reduction benefits.

Early research suggests GLP‑1 drugs may reduce alcohol intake by dampening reward signaling and hedonic hunger, sparking interest among diabetes clinicians about the potential of GLP-1 alcohol use reduction. While findings so far are promising, understanding the nuances of the evidence is essential when talking with patients. This article explores …

Read More »

GLP‑1s and Sleep Apnea: A New Option for Treating Both Breathing and Blood Sugar

Man with sleep apnea using CPAP machine, surrounded by diabetes medications, glucose monitor, and lung illustration.

GLP‑1 receptor agonists have transformed the way we manage type 2 diabetes and obesity—but could they also play a role in sleep apnea treatment? The intersection of GLP-1 sleep apnea benefits is gaining attention, with new evidence suggesting these therapies may offer more than just weight loss. With diabetes and …

Read More »

GLP‑1s for Obesity: What Long‑Term Treatment Really Means for Diabetes Care

Doctor consulting an obese patient with GLP-1 medication pen, glucose monitor, and medical tools on desk, highlighting obesity and diabetes treatment.

The rise of GLP-1 obesity treatment has transformed how clinicians approach patients with both obesity and diabetes. These therapies, originally developed for glucose control, now show robust benefits in weight management. However, as use becomes more common in clinical practice, endocrinologists and primary care providers must balance glycemic outcomes, weight …

Read More »

Bridging the GLP‑1 Access Gap: Equity Strategies in a High‑Demand Era

Diverse healthcare team discussing GLP‑1 therapy access with medical tools and cost symbols in the foreground, illustrating treatment equity challenges.

As GLP‑1 drugs become more widely used for managing type 2 diabetes and obesity, concerns about access disparities have intensified. Unequal distribution and affordability threaten to create a two-tier healthcare system—where only those with greater means receive these life-changing therapies. In this article, we explore the concept of GLP‑1 access …

Read More »